1. Home
  2. ZEO vs TNXP Comparison

ZEO vs TNXP Comparison

Compare ZEO & TNXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZEO
  • TNXP
  • Stock Information
  • Founded
  • ZEO 2005
  • TNXP 2007
  • Country
  • ZEO United States
  • TNXP United States
  • Employees
  • ZEO N/A
  • TNXP N/A
  • Industry
  • ZEO
  • TNXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZEO
  • TNXP Health Care
  • Exchange
  • ZEO NYSE
  • TNXP Nasdaq
  • Market Cap
  • ZEO 14.6M
  • TNXP 15.1M
  • IPO Year
  • ZEO N/A
  • TNXP N/A
  • Fundamental
  • Price
  • ZEO $1.69
  • TNXP $0.15
  • Analyst Decision
  • ZEO
  • TNXP Strong Buy
  • Analyst Count
  • ZEO 0
  • TNXP 2
  • Target Price
  • ZEO N/A
  • TNXP $53.50
  • AVG Volume (30 Days)
  • ZEO 3.1M
  • TNXP 26.1M
  • Earning Date
  • ZEO 11-20-2024
  • TNXP 11-07-2024
  • Dividend Yield
  • ZEO N/A
  • TNXP N/A
  • EPS Growth
  • ZEO N/A
  • TNXP N/A
  • EPS
  • ZEO 0.67
  • TNXP N/A
  • Revenue
  • ZEO $95,455,763.00
  • TNXP $12,458,000.00
  • Revenue This Year
  • ZEO N/A
  • TNXP $62.53
  • Revenue Next Year
  • ZEO N/A
  • TNXP $26.17
  • P/E Ratio
  • ZEO $2.58
  • TNXP N/A
  • Revenue Growth
  • ZEO N/A
  • TNXP N/A
  • 52 Week Low
  • ZEO $1.14
  • TNXP $0.12
  • 52 Week High
  • ZEO $12.34
  • TNXP $22.08
  • Technical
  • Relative Strength Index (RSI)
  • ZEO 42.71
  • TNXP 32.40
  • Support Level
  • ZEO $1.55
  • TNXP $0.14
  • Resistance Level
  • ZEO $1.96
  • TNXP $0.18
  • Average True Range (ATR)
  • ZEO 0.37
  • TNXP 0.02
  • MACD
  • ZEO -0.01
  • TNXP 0.02
  • Stochastic Oscillator
  • ZEO 8.08
  • TNXP 28.11

About ZEO ZEO ENERGY CORP

Zeo Energy Corp is a vertically integrated provider of residential solar energy systems, other energy efficient equipment and related services currently serving customers in Florida, Texas, Arkansas, and Missouri. Its primary business activity is selling and installing residential solar energy systems that homeowners use to supplement the amount of usable electricity required to power their homes.

About TNXP Tonix Pharmaceuticals Holding Corp.

Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.

Share on Social Networks: